These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 8848410

  • 1. [Level of neuropeptide Y in serum of patients with chronic congestive heart failure].
    Halawa B.
    Pol Arch Med Wewn; 1996 May; 95(5):427-32. PubMed ID: 8848410
    [Abstract] [Full Text] [Related]

  • 2. Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure.
    Feng QP, Hedner T, Andersson B, Lundberg JM, Waagstein F.
    Br Heart J; 1994 Mar; 71(3):261-7. PubMed ID: 8142196
    [Abstract] [Full Text] [Related]

  • 3. [Concentration of neuropeptide Y in serum of patients with primary hypertension].
    Halawa B, Salomon P.
    Pol Arch Med Wewn; 1996 May; 95(5):420-6. PubMed ID: 8848409
    [Abstract] [Full Text] [Related]

  • 4. [Effects of shenmai injection on plasma neuropeptide Y, endothelin and atrial natriuretic polypeptide in heart failure patients].
    Wu H, Lu Y, Zhang Q.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Nov; 19(11):653-5. PubMed ID: 11783155
    [Abstract] [Full Text] [Related]

  • 5. Neuropeptide Y, noradrenaline and invasive haemodynamic data in mild to moderate chronic congestive heart failure.
    Ullman B, Jensen-Urstad M, Hulting J, Lundberg JM.
    Clin Physiol; 1993 Jul; 13(4):409-18. PubMed ID: 8370239
    [Abstract] [Full Text] [Related]

  • 6. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.
    Daggubati S, Parks JR, Overton RM, Cintron G, Schocken DD, Vesely DL.
    Cardiovasc Res; 1997 Nov; 36(2):246-55. PubMed ID: 9463636
    [Abstract] [Full Text] [Related]

  • 7. Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.
    van den Berg MP, Tjeerdsma G, Jan de Kam P, Boomsma F, Crijns HJ, van Veldhuisen DJ.
    Eur J Heart Fail; 2002 Jun; 4(3):255-62. PubMed ID: 12034149
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S, Gorini M, Salio M, Lucci D, Latini R, Maggioni AP.
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure.
    Ullman B, Lindvall K, Lundberg JM, Sigurdsson A, Swedberg K.
    Clin Physiol; 1994 Mar; 14(2):123-34. PubMed ID: 8205743
    [Abstract] [Full Text] [Related]

  • 12. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T, Kato M, Ogino K, Osaki S, Igawa O, Hisatome I, Shigemasa C.
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [Abstract] [Full Text] [Related]

  • 13. [Significance of the changes of plasma endothelin, norepinephrine and atrial natriuretic peptide in treatment of heart failure with beta-blocker].
    Li G, Xie X, Zhou H, Huang Y.
    Hunan Yi Ke Da Xue Xue Bao; 1999 Aug; 24(5):448-50. PubMed ID: 12080680
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Elevation of plasma neuropeptide Y levels in congestive heart failure.
    Maisel AS, Scott NA, Motulsky HJ, Michel MC, Boublik JH, Rivier JE, Ziegler M, Allen RS, Brown MR.
    Am J Med; 1989 Jan; 86(1):43-8. PubMed ID: 2910096
    [Abstract] [Full Text] [Related]

  • 16. Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.
    Dubois-Randé JL, Comoy E, Merlet P, Benvenuti C, Carville C, Hittinger L, Macquin-Mavier I, Bohuon C, Castaigne A.
    Eur Heart J; 1992 Sep; 13(9):1233-8. PubMed ID: 1396834
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
    Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Fujii M, Matsumoto T, Yamamoto T, Takayama T, Kinoshita M.
    J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
    [Abstract] [Full Text] [Related]

  • 19. Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure.
    Tkacova R, Liu PP, Naughton MT, Bradley TD.
    J Am Coll Cardiol; 1997 Sep; 30(3):739-45. PubMed ID: 9283534
    [Abstract] [Full Text] [Related]

  • 20. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R, Pousset F, Chafirovskaïa O, Carayon A, Hulot JS, Thomas D, Komajda M.
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.